Advanced Biomed Inc

Research Advanced Biomed Inc (ADVB) on Bullrun: market cap USD 8.68M, P/E 33.4. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 8.68M; P/E is 33.4.

Peer valuation comparison

Latest P/E is 33.35x versus a Healthcare sector median of 24.61x (35.5% above).

Latest P/E is 33.35x versus a United States median of 23.85x (39.8% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025n/a-USD 3.26M-USD 5.86Mn/a-0.16USD 2.87MUSD 21.09KUSD 3.48M
FY2024USD 0-USD 2.78M-USD 2.20Mn/a-0.14USD 2.61MUSD 126.74KUSD 1.66M
FY2023USD 0-USD 3.73M-USD 3.18Mn/a-3.45USD 2.62MUSD 235.37KUSD 1.31M
FY2022USD 0-USD 4.03M-USD 2.05Mn/a-0.64USD 4.78MUSD 468.87KUSD 3.49M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-09USD 8.68M33.4n/an/a
20252025-12-31USD 6.32M44.9n/an/a

About Advanced Biomed Inc

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Advanced Biomed Inc's market cap?

Advanced Biomed Inc's market capitalization is USD 8.68M.

What is Advanced Biomed Inc's P/E ratio?

Advanced Biomed Inc's price-to-earnings (P/E) ratio is 33.4.

What does Advanced Biomed Inc do?

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan.